B’spoke 4.4x STRENGTH OMEGA-3 CLINICAL USE PROTOCOL FOR HEALTHCARE PRACTITIONERS
05 Jan 2026

B’spoke 4.4x STRENGTH OMEGA-3 CLINICAL USE PROTOCOL FOR HEALTHCARE PRACTITIONERS

Omega-3 fatty acids—principally eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)—have been extensively evaluated in clinical research across a range of health domains, including cardiometabolic risk modulation, inflammatory conditions, neurological function, and developmental health. Despite a substantial and growing evidence base, clinical outcomes associated with omega-3 supplementation...

Read more